Skip to main content
. 2018 Sep 25;109(11):3657–3661. doi: 10.1111/cas.13787

Figure 1.

Figure 1

Clinical course of the patient. A, B, Computed tomography scans of the chest showing the primary mass (arrow) in the lower left lobe of the lung immediately before (A) and 1 month after (B) the onset of afatinib treatment. C, Time course (year/month) of serum CEA concentration from the onset of afatinib treatment